Related references
Note: Only part of the references are listed.Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia
Luke W. Thomas et al.
COMMUNICATIONS BIOLOGY (2021)
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Adriana Estrada-Bernal et al.
CLINICAL CANCER RESEARCH (2021)
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E. Scharping et al.
NATURE IMMUNOLOGY (2021)
Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study
Gabi U. Dachs et al.
FRONTIERS IN ONCOLOGY (2021)
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer
Michael Skwarski et al.
CLINICAL CANCER RESEARCH (2021)
Superoxide produced by mitochondrial site IQ inactivates cardiac succinate dehydrogenase and induces hepatic steatosis in Sod2 knockout mice
Hoi-Shan Wong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid
McLane J. Watson et al.
NATURE (2021)
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
Aparna Hegde et al.
CLINICAL CANCER RESEARCH (2021)
Lost in application: Measuring hypoxia for radiotherapy optimisation
Niluja Thiruthaneeswaran et al.
EUROPEAN JOURNAL OF CANCER (2021)
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Toni K. Choueiri et al.
NATURE MEDICINE (2021)
Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
Dan P. Zandberg et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Hypoxia-inducible factor?prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease
Volker H. Haase
KIDNEY INTERNATIONAL SUPPLEMENTS (2021)
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor
Anna Skwarska et al.
CELL CHEMICAL BIOLOGY (2021)
Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models
Manal Mehibel et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Linking EMT programmes to normal and neoplastic epithelial stem cells
Arthur W. Lambert et al.
NATURE REVIEWS CANCER (2021)
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Xi Chen et al.
NATURE REVIEWS CANCER (2021)
Impact of hypoxia on DNA repair and genome integrity
Alanna R. Kaplan et al.
MUTAGENESIS (2020)
IMMUNITY, HYPOXIA, AND METABOLISM-THE MENAGE A TROIS OF CANCER: IMPLICATIONS FOR IMMUNOTHERAPY
Carla Riera-Domingo et al.
PHYSIOLOGICAL REVIEWS (2020)
Carbonic anhydrase IX and acid transport in cancer
Holger M. Becker
BRITISH JOURNAL OF CANCER (2020)
Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils
Karim Mahiddine et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cellular adaptation to hypoxia through hypoxia inducible factors and beyond
Pearl Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Tumor hypermetabolism confers resistance to immunotherapy
Arthur Liu et al.
SEMINARS IN CANCER BIOLOGY (2020)
Divergent mutational processes distinguish hypoxic and normoxic tumours
Vinayak Bhandari et al.
NATURE COMMUNICATIONS (2020)
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C. McDonald et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism
Isha H. Jain et al.
CELL (2020)
Radiation Damage to Tumor Vasculature Initiates a Program That Promotes Tumor Recurrences
J. Martin Brown
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
Blake A. Winn et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
Ewen D. D. Calder et al.
TETRAHEDRON (2020)
Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib
Bjoern Bielec et al.
BIOORGANIC CHEMISTRY (2020)
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights
Sachin Puri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Immune Sensing Mechanisms that Discriminate Self from Altered Self and Foreign Nucleic Acids
Eva Bartok et al.
IMMUNITY (2020)
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Jackie E. Bader et al.
MOLECULAR CELL (2020)
Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma
Zachary A. Bacigalupa et al.
CANCER LETTERS (2020)
The Role of HIF in Immunity and Inflammation
Anne F. McGettrick et al.
CELL METABOLISM (2020)
Oncometabolites suppress DNA repair by disrupting local chromatin signalling
Parker L. Sulkowski et al.
NATURE (2020)
Na+controls hypoxic signalling by the mitochondrial respiratory chain
Pablo Hernansanz-Agustin et al.
NATURE (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radiochemotherapy
Sebastian Zschaeck et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
Stephen M. Hatfield et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
Chris P. Guise et al.
MOLECULES (2020)
Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)
Mette Sakso et al.
RADIOTHERAPY AND ONCOLOGY (2020)
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
Rouven Hoefflin et al.
NATURE COMMUNICATIONS (2020)
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
Ashvin R. Jaiswal et al.
CANCER IMMUNOLOGY RESEARCH (2020)
2-Nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche
Naoyoshi Koike et al.
COMMUNICATIONS BIOLOGY (2020)
Hypoxia Induces Transcriptional and Translational Downregulation of the Type I IFN Pathway in Multiple Cancer Cell Types
Ana Miar et al.
CANCER RESEARCH (2020)
2-Oxoglutarate-dependent dioxygenases in cancer
Julie-Aurore Losman et al.
NATURE REVIEWS CANCER (2020)
DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumor immunotolerance
Flora D'Anna et al.
GENOME BIOLOGY (2020)
Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study
Geraud N. Sansom et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Causes, consequences, and therapy of tumors acidosis
Smitha R. Pillai et al.
CANCER AND METASTASIS REVIEWS (2019)
Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes
Nazanin Rohani et al.
CANCER RESEARCH (2019)
Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers
Colles Price et al.
CANCER RESEARCH (2019)
Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs
R. K. Jackso et al.
CLINICAL ONCOLOGY (2019)
Hypoxia induces rapid changes to histone methylation and reprograms chromatin
Michael Batie et al.
SCIENCE (2019)
An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect
Cho Rong Hong et al.
NEOPLASIA (2019)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer
Ahmed Salem et al.
CLINICAL CANCER RESEARCH (2019)
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma
Daniel R. McGowan et al.
EUROPEAN JOURNAL OF CANCER (2019)
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
Paul C. McDonald et al.
GASTROENTEROLOGY (2019)
Hypoxia-active nanoparticles used in tumor theranostic
Yaqin Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide
Francis W. Hunter et al.
MOLECULAR PHARMACOLOGY (2019)
Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors
Benjamin D. Dickson et al.
MOLECULES (2019)
Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
Alanna R. Kaplan et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Shawn C. Chafe et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Jie Deng et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy
Magali Lecavalier-Barsoum et al.
BRITISH JOURNAL OF CANCER (2019)
Reduced CTL motility and activity in avascular tumor areas
Yoav Manaster et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer
Jill M. Brooks et al.
CLINICAL CANCER RESEARCH (2019)
Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy
Steffen Loeck et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
Norma Masson et al.
SCIENCE (2019)
The Natural Compound Climacostol as a Prodrug Strategy Based on pH Activation for Efficient Delivery of Cytotoxic Small Agents
Elisabetta Catalani et al.
FRONTIERS IN CHEMISTRY (2019)
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
Asmaa El-Kenawi et al.
BRITISH JOURNAL OF CANCER (2019)
Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
Reena P. Thomas et al.
CLINICAL CANCER RESEARCH (2019)
Study of SHMT2 Inhibitors and Their Binding Mechanism by Computational Alanine Scanning
Liping He et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361
Way Wua Wong et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors
Huiqiang Wei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
VISTA is an acidic pH-selective ligand for PSGL-1
Robert J. Johnston et al.
NATURE (2019)
Pharmacologic Targeting of Hypoxia-Inducible Factors
Gregg L. Semenza
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
Christopher Groth et al.
BRITISH JOURNAL OF CANCER (2019)
Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis
Hoibin Jeong et al.
CANCER RESEARCH (2019)
Beware of Clinical Trials of DNA Repair Inhibitors
J. Martin Brown
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury
Sahra Bodo et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Elena Andreucci et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers
Kaye J. Williams et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
Linda Spiegelberg et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
STEAP4 ISH and IHC diagnostics for Tarloxotinib activation in EGFR/HER2 mutant cancers
Hui Yu et al.
CANCER RESEARCH (2019)
Hypoxia-targeted drug delivery
Amit Sharma et al.
CHEMICAL SOCIETY REVIEWS (2019)
Role of hypoxia-activated prodrugs in combination with radiation therapy: An in silico approach
Cameron Meaney et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2019)
Intratumoral heterogeneity and hypoxia gene expression signatures: Is a single biopsy adequate?
Jelena Lukovic et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma
Yana G. Najjar et al.
JCI INSIGHT (2019)
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Dylan G. Ryan et al.
NATURE METABOLISM (2019)
Sumoylation of the histone demethylase KDM4A is required for binding to tumor suppressor p53 in HCT116 colon cancer cell lines
Seung Eun Yu et al.
ANIMAL CELLS AND SYSTEMS (2018)
In vitro evaluation of the monoclonal antibody Cu-64-IgG M75 against human carbonic anhydrase IX and its in vivo imaging
Adam Cepa et al.
APPLIED RADIATION AND ISOTOPES (2018)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
Shimpei Iikuni et al.
THERANOSTICS (2018)
Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects
Cho Rong Hong et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo
Shen-Han Lee et al.
BRITISH JOURNAL OF CANCER (2018)
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D. Courtney et al.
CELL METABOLISM (2018)
Unexpected pharmacokinetics of evofosfamide observed in phase III MAESTRO study.
Jack P. Higgins et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
Martin Benej et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Systems analysis of intracellular pH vulnerabilities for cancer therapy
Erez Persi et al.
NATURE COMMUNICATIONS (2018)
Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures
Cho R. Hong et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Tumour-targeting bacteria engineered to fight cancer
Shibin Zhou et al.
NATURE REVIEWS CANCER (2018)
Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
Gregg L. Semenza
EMBO JOURNAL (2017)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
In Vivo Imaging Reveals Significant Tumor Vascular Dysfunction and Increased Tumor Hypoxia-Inducible Factor-1α Expression Induced by High Single-Dose Irradiation in a Pancreatic Tumor Model
Azusa Maeda et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy
Moana Tercel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
Min-Zu Wu et al.
NATURE CELL BIOLOGY (2017)
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
Parker L. Sulkowski et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability
Jennifer M. J. Jongen et al.
ONCOTARGET (2017)
The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
Giusy Di Conza et al.
CELL REPORTS (2017)
Endothelial Progenitors: A Consensus Statement on Nomenclature
Reinhold J. Medina et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
Tris-base buffer: a promising new inhibitor for cancer progression and metastasis
Arig Ibrahim-Hashim et al.
CANCER MEDICINE (2017)
Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells
Shalini Sethumadhavan et al.
PLOS ONE (2017)
Non-heme dioxygenases in tumor hypoxia: They're all bound with the same fate
Roy Anindya
DNA REPAIR (2017)
Transport of drugs from blood vessels to tumour tissue
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2017)
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Asis Palazon et al.
CANCER CELL (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
James P. B. O'Connor et al.
CANCER RESEARCH (2016)
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Shari Pilon-Thomas et al.
CANCER RESEARCH (2016)
Quantitative and qualitative analysis of [18F]FDG and [18F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome
Edward E. Graves et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
Francis W. Hunter et al.
BRITISH JOURNAL OF CANCER (2016)
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
A. Ari Hakimi et al.
CANCER CELL (2016)
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces
Mark C. Lloyd et al.
CANCER RESEARCH (2016)
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
David Clever et al.
CELL (2016)
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
David Kung-Chun Chiu et al.
HEPATOLOGY (2016)
The impact of hypoxia on tumor-associated macrophages
Anne-Theres Henze et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
O2 sensing, mitochondria and ROS signaling: The fog is lifting
Gregory B. Waypa et al.
MOLECULAR ASPECTS OF MEDICINE (2016)
miR-155 Overexpression Promotes Genomic Instability by Reducing High-fidelity Polymerase Delta Expression and Activating Error-Prone DSB Repair
Jennifer R. Czochor et al.
MOLECULAR CANCER RESEARCH (2016)
Peroxiredoxins in Regulation of MAPK Signalling Pathways; Sensors and Barriers to Signal Transduction
Heather R. Latimer et al.
MOLECULES AND CELLS (2016)
Tumour hypoxia causes DNA hyper-methylation by reducing TET activity
Bernard Thienpont et al.
NATURE (2016)
Targeting renal cell carcinoma with a HIF-2 antagonist
Wenfang Chen et al.
NATURE (2016)
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate
Petros A. Tyrakis et al.
NATURE (2016)
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho et al.
NATURE (2016)
Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs
Liam J. O'Connor et al.
NATURE PROTOCOLS (2016)
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
Thomas M. Ashton et al.
NATURE COMMUNICATIONS (2016)
Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
Gabriela Jimenez-Valerio et al.
CELL REPORTS (2016)
Prognostic Significance of Carbonic Anhydrase IX expression in Cancer Patients: A Meta-Analysis
Simon J. A. van Kuijk et al.
FRONTIERS IN ONCOLOGY (2016)
pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates
Kelly E. Burns et al.
SCIENTIFIC REPORTS (2016)
MAESTRO: A randomized, double-blind phase III study of evofosfamide (Evo) in combination with gemcitabine (Gem) in previously untreated patients (pts) with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC)
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole
N. C. Dhani et al.
BRITISH JOURNAL OF CANCER (2015)
Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs
Francis W. Hunter et al.
CANCER RESEARCH (2015)
Hypoxia Induces Production of L-2-Hydroxyglutarate
Andrew M. Intlekofer et al.
CELL METABOLISM (2015)
Hypoxia-Mediated Increases in L-2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress
William M. Oldham et al.
CELL METABOLISM (2015)
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
Mitesh J. Borad et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
Yao Liu et al.
JOURNAL OF HEPATOLOGY (2015)
Suppressors of superoxide production from mitochondrial complex III
Dam L. Orr et al.
NATURE CHEMICAL BIOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
Haiquan Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
New ways to image and target tumour hypoxia and its molecular responses
Ludwig J. Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration
Z. Wen et al.
ONCOGENE (2015)
Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5
Jingli Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs
Francis W. Hunter et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
M. J. Walters et al.
BRITISH JOURNAL OF CANCER (2014)
Is Indirect Cell Death Involved in Response of Tumors to Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy?
Chang W. Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
Mateya E. Trinkaus et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2014)
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
Stephen M. Hatfield et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer
Francis W. Hunter et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Direct measurement of local oxygen concentration in the bone marrow of live animals
Joel A. Spencer et al.
NATURE (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Edward T. Chouchani et al.
NATURE (2014)
Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
Jiangbin Ye et al.
CANCER DISCOVERY (2014)
CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A
Cindy Cazares-Koerner et al.
ACS CHEMICAL BIOLOGY (2013)
Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival
Luke R. G. Pike et al.
BIOCHEMICAL JOURNAL (2013)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Veronica Estrella et al.
CANCER RESEARCH (2013)
In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
Paulo A. Gameiro et al.
CELL METABOLISM (2013)
SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase
Murilo T. D. Bueno et al.
EPIGENETICS (2013)
Zinc Finger Nuclease Knock-out of NADPH: Cytochrome P450 Oxidoreductase (POR) in Human Tumor Cell Lines Demonstrates That Hypoxia-activated Prodrugs Differ in POR Dependence
Jiechuang Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Two phases of disulfide bond formation have differing requirements for oxygen
Marianne Koritzinsky et al.
JOURNAL OF CELL BIOLOGY (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
Tor-Christian Aase Johannessen et al.
NEURO-ONCOLOGY (2013)
PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS
Kasper M. Rouschop et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Roles of Reactive Oxygen Species and Autophagy in Mediating the Tolerance of Tumor Cells to Cycling Hypoxia
Marianne Koritzinsky et al.
SEMINARS IN RADIATION ONCOLOGY (2013)
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer
Veronique M. Neumeister et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Chromatin as an oxygen sensor and active player in the hypoxia response
Andrew Melvin et al.
CELLULAR SIGNALLING (2012)
A Strategy for Selective O6-Alkylguanine-DNA Alkyltransferase Depletion Under Hypoxic Conditions
Philip G. Penketh et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
The 2-Nitroimidazole EF5 Is a Biomarker for Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under Hypoxia
Jingli Wang et al.
CLINICAL CANCER RESEARCH (2012)
Carbonic Anhydrase IX Interacts with Bicarbonate Transporters in Lamellipodia and Increases Cell Migration via Its Catalytic Domain
Eliska Svastova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
Geert O. Janssens et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
Fanying Meng et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Andrew R. Mullen et al.
NATURE (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery
John N. Kheir et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Passing the baton: the HIF switch
Mei Yee Koh et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Diflavin Oxidoreductases Activate the Bioreductive Prodrug PR-104A under Hypoxia
Christopher P. Guise et al.
MOLECULAR PHARMACOLOGY (2012)
Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer
Kasper Toustrup et al.
CANCER RESEARCH (2011)
Clinical trials of antioxidants as cancer prevention agents: Past, present, and future
Michael Goodman et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
HYPOFRACTIONATION RESULTS IN REDUCED TUMOR CELL KILL COMPARED TO CONVENTIONAL FRACTIONATION FOR TUMORS WITH REGIONS OF HYPOXIA
David J. Carlson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Hypoxia Triggers AMPK Activation through Reactive Oxygen Species-Mediated Activation of Calcium Release-Activated Calcium Channels
Paul T. Mungai et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Hypoxia Leads to Na,K-ATPase Downregulation via Ca2+ Release-Activated Ca2+ Channels and AMPK Activation
Galina A. Gusarova et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Jonathan W. Wojtkowiak et al.
MOLECULAR PHARMACEUTICS (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis
Jens Overgaard
RADIOTHERAPY AND ONCOLOGY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
F. M. Buffa et al.
BRITISH JOURNAL OF CANCER (2010)
The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3
Christopher P. Guise et al.
CANCER RESEARCH (2010)
Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability
Isabel M. Pires et al.
CANCER RESEARCH (2010)
Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
Norman Chan et al.
CANCER RESEARCH (2010)
Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors
Kevin O. Hicks et al.
CLINICAL CANCER RESEARCH (2010)
Targeting Hypoxic Cells through the DNA Damage Response
Monica Olcina et al.
CLINICAL CANCER RESEARCH (2010)
Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis
Norihiko Takeda et al.
GENES & DEVELOPMENT (2010)
STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER
J. Martin Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
Peter J. Hoskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
Lester J. Peters et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)
Lenny Dang et al.
NATURE (2010)
Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130
Denise Campisi Hegan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
Ian F. Robey et al.
CANCER RESEARCH (2009)
Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated dinitrobenzamide mustard PR-104A
Yongchuan Gu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Mark W. Dewhirst
RADIATION RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells
G-One Ahn et al.
CANCER CELL (2008)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance
Norman Chan et al.
CANCER RESEARCH (2008)
Amplifying tumour-specific replication lesions by DNA repair inhibitors - A new era in targeted cancer therapy
Thomas Helleday
EUROPEAN JOURNAL OF CANCER (2008)
Efficacy of novel hypoxic cell sensitiser doranidazole in the treatment of locally advanced pancreatic cancer: Long-term results of a placebo-control led randomised study
Katsuyuki Karasawa et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: Comparison of the dinitrobenzamide mustard PR-104A and tirapazamine
Kevin O. Hicks et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Chemical radiosensitizers for use in radiotherapy
P. Wardman
CLINICAL ONCOLOGY (2007)
Detection and characterization of tumor hypoxia using pO2 histography
Peter Vaupel et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V. Patterson et al.
CLINICAL CANCER RESEARCH (2007)
Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia
R. S. Bindra et al.
ONCOGENE (2007)
The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
William G. Kaelin
CLINICAL CANCER RESEARCH (2007)
Hypoxia in head and neck cancer: Studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins
Danny Rischin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Bystander effects of bioreductive drugs: Potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards
William R. Wilson et al.
RADIATION RESEARCH (2007)
Hypoxia-inducible factor-1 mediates the expression of DNA polymerase ι in human tumor cells
Akiko Ito et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs
Kevin O. Hicks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Succinate dehydrogenase and fumarate hydratase:: linking mitochondrial dysfunction and cancer
A. King et al.
ONCOGENE (2006)
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine:: A substudy of Trans-Tasman Radiation Oncology Group study 98.02
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
LE Gerweck et al.
MOLECULAR CANCER THERAPEUTICS (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Hypoxia-induced down-regulation of BRCA1 expression by E2Fs
RS Bindra et al.
CANCER RESEARCH (2005)
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study
M Nordsmark et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130
J Garriga et al.
CELL CYCLE (2004)
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
DJ Ceradini et al.
NATURE MEDICINE (2004)
Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides
SS Shinde et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Oxygen dependence of the metabolic activation and cytotoxicity of tirapazamine: Implications for extravascular transport and activity in tumors
KO Hicks et al.
RADIATION RESEARCH (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
Tumor response to radiotherapy regulated by endothelial cell apoptosis
M Garcia-Barros et al.
SCIENCE (2003)
ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation
EM Hammond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The mechanism of action of radios ensitization of conventional chemotherapeutic agents
TS Lawrence et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α
C Koumenis et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species
SM Bailey et al.
BIOCHEMICAL PHARMACOLOGY (2001)
AQ4N: a new approach to hypoxia-activated cancer chemotherapy
LH Patterson et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
